ArticlePLOS global public health2025
TB and diabetes in Eswatini: Addressing suboptimal treatment outcomes through integrated services.
Article in PLOS global public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Tuberculosis (TB) remains a significant public health challenge in Eswatini, a country with the highest global HIV prevalence. Diabetes mellitus (DM) is increasingly common among people newly diagnosed with TB, contributing to suboptimal TB treatment outcomes, including relapse and death. The DETECT study employed a multi-method approach to assess the prevalence and DM impact on TB treatment outcomes among adults with TB in 10 Ministry of Health facilities in Eswatini, and explore barriers and facilitators to integrating TB/DM services. DM screening was conducted using laboratory-based glycated hemoglobin (A1c) testing, with DM defined as A1c ≥ 6.5% and preDM as A1c 5.7-6.4%. We conducted logistic regression to assess DM's impact on TB treatment outcomes and 40 in-depth interviews with key stakeholders involved with TB services to explore barriers and facilitators to TB/DM service integration. Among the 373 adults diagnosed with TB and tested for DM, 13.4% had DM, 41.8% had preDM, and 44.8% had a normal A1c. The odds of poor TB treatment outcomes were 3.53 times higher (95%CI: 1.72-7.32) among those with DM compared to those without DM, after adjusting for age, HIV status, and new versus previously treated TB, highlighting the need for early DM diagnosis and treatment. Patient education and support, adequate screening resources, and community engagement were identified as facilitators of TB/DM service integration. Barriers included health system financial constraints, a perceived lack of need for exercise, insufficiently trained TB healthcare providers, inadequate supplies, societal stigma, limited patient autonomy in decision-making, and the unaffordability of healthy diets. The study found a high prevalence of DM/preDM among adults with TB in Eswatini, with DM significantly increasing the odds of poor TB treatment outcomes, irrespective of HIV status. The findings underscore the urgent need for enhanced tools and strategies to support healthcare providers in integrating TB and DM services effectively.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.